[HTML][HTML] Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease

J Chen, X Wang, T Xia, Y Bi, B Liu, J Fu… - Biomedicine & …, 2021 - Elsevier
Recent studies demonstrated that dihydromyricetin (DHM) has prominent therapeutic effects
on liver injury and liver cancer. By summarizing the current preclinical in vitro and in vivo …

The versatile effects of dihydromyricetin in health

H Li, Q Li, Z Liu, K Yang, Z Chen… - Evidence‐Based …, 2017 - Wiley Online Library
Dihydromyricetin is a flavonoid isolated from Ampelopsis grossedentata, which is
traditionally used in China. Dihydromyricetin exhibits health‐benefiting activities with …

Green synthesis and characterization of zirconium oxide nanoparticles by using a native Enterobacter sp. and its antifungal activity against bayberry twig blight …

T Ahmed, H Ren, M Noman, M Shahid, M Liu, MA Ali… - NanoImpact, 2021 - Elsevier
Pestalotiopsis versicolor is a most destructive fungal pathogen that causes twig blight
disease in bayberry. For the last seven years, it is difficult to control this pathogen due to its …

Antiproliferative and apoptosis inducing effects of citral via p53 and ROS-induced mitochondrial-mediated apoptosis in human colorectal HCT116 and HT29 cell lines

BY Sheikh, MMR Sarker, MNA Kamarudin… - Biomedicine & …, 2017 - Elsevier
Despite various anticancer reports, antiproliferative and apoptosis inducing activity of citral
in HCT116 and HT29 cells have never been reported. This study aimed to evaluate the …

H19-derived miR-675 contributes to bladder cancer cell proliferation by regulating p53 activation

C Liu, Z Chen, J Fang, A Xu, W Zhang, Z Wang - Tumor Biology, 2016 - Springer
Abstract Long noncoding RNA 19 (H19) has been shown to promote bladder cancer cell
proliferation and metastasis. However, little is known about how miR-675, mature product of …

TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway

L Chen, J Qing, Y Xiao, X Huang, Y Chi, Z Chen - BMC cancer, 2022 - Springer
Background T-cell immunoglobulin mucin-1 (TIM-1) has been reported to be associated with
the biological behavior of several malignant tumors; however, it is not clear whether it has a …

[HTML][HTML] Recent update on application of dihydromyricetin in metabolic related diseases

Y Wang, J Wang, H Xiang, P Ding, T Wu, G Ji - Biomedicine & …, 2022 - Elsevier
As a new type of natural flavonoids, dihydromyricetin (DMY) has attracted more and more
attention. It has a series of pharmacological effects, such as anti-inflammatory, anti-tumor …

Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis

T Xiao, Y Wei, M Cui, X Li, H Ruan, L Zhang, J Bao… - Phytomedicine, 2021 - Elsevier
Abstract Background COVID-19 (Coronavirus Disease-2019) has spread widely around the
world and impacted human health for millions. The lack of effective targeted drugs and …

Dihydromyricetin ameliorates oleic acid-induced lipid accumulation in L02 and HepG2 cells by inhibiting lipogenesis and oxidative stress

C Xie, Z Chen, C Zhang, X Xu, J Jin, W Zhan, T Han… - Life Sciences, 2016 - Elsevier
Aims Dihydromyricetin (DMY), a flavonoid component isolated from Ampelopsis
grossedentata, was recently reported to ameliorate nonalcoholic fatty liver disease (NAFLD) …

[HTML][HTML] Dihydromyricetin alleviates carbon tetrachloride-induced acute liver injury via JNK-dependent mechanism in mice

J Xie, J Liu, TM Chen, Q Lan, QY Zhang… - World Journal of …, 2015 - ncbi.nlm.nih.gov
AIM: To assess the effects of dihydromyricetin (DHM) as a hepatoprotective candidate in
reducing hepatic injury and accelerating hepatocyte proliferation after carbon tetrachloride …